Literature DB >> 11549093

Evaluation of antibiotics for treatment of cattle infected with Leptospira borgpetersenii serovar hardjo.

D P Alt1, R L Zuerner, C A Bolin.   

Abstract

OBJECTIVE: To evaluate antibiotics for treatment of cattle with leptospirosis caused by Leptospira borgpetersenii serovar hardjo.
DESIGN: Randomized controlled trial. ANIMALS: 42 healthy mixed-breed cattle. PROCEDURE: Cattle were inoculated via conjunctival instillation with L. borgpetersenii serovar hardjo. After infection and urinary shedding of L. borgpetersenii were confirmed, cattle were treated with various antibiotics. To determine effectiveness of antibiotic treatment, urinary shedding of L. borgpetersenii was monitored for 4 to 6 weeks after administration of antibiotics, using darkfield microscopic examination, microbial culture, immunofluorescence testing, and a polymerase chain reaction assay.
RESULTS: All inoculated cattle developed leptospirosis and shed leptospires in their urine. The following antibiotic treatments resulted in elimination of urinary shedding of leptospires: a single injection of oxytetracycline (20 mg/kg 19 mg/lb] of body weight, IM), tilmicosin (10 mg/kg [4.5 mg/lb], SC), or a combination product that contained dihydrostreptomycin-penicillin G (25 mg/kg [11.4 mg/lb], IM) or multiple injections of ceftiofur sodium (2.2 or 5 mg/kg [1 or 2.3 mg/lb], IM, once daily for 5 days, or 20 mg/kg, IM, once daily for 3 days). CONCLUSIONS AND CLINICAL RELEVANCE: Successful resolution of leptospirosis in cattle by administration of dihydrostreptomycin-penicillin G confirms results obtained by other investigators. Three other antibiotics (oxytetracycline, tilmicosin, and ceftiofur) also were effective for resolving leptospirosis and may be useful substitutes for dihydrostreptomycin, an antibiotic that is no longer available for use in food-producing animals in the United States. Cost, safety, and withdrawal times of these various treatment options need to be considered.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549093     DOI: 10.2460/javma.2001.219.636

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  7 in total

1.  In vitro and in vivo activity of first generation cephalosporins against Leptospira.

Authors:  Brande M Harris; Peter J Blatz; Mary K Hinkle; Suzanne McCall; Miriam L Beckius; Katrin Mende; Janelle L Robertson; Matthew E Griffith; Clinton K Murray; Duane R Hospenthal
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

2.  A Leptospira borgpetersenii serovar Hardjo vaccine induces a Th1 response, activates NK cells, and reduces renal colonization.

Authors:  Richard L Zuerner; David P Alt; Mitchell V Palmer; Tyler C Thacker; Steven C Olsen
Journal:  Clin Vaccine Immunol       Date:  2011-02-02

3.  Antibiotic Efficacy in Eliminating Leptospiruria in California Sea Lions (Zalophus californianus) Stranding with Leptospirosis.

Authors:  K C Prager; David P Alt; Michael G Buhnerkempe; Denise J Greig; Renee L Galloway; Qingzhong Wu; Frances M D Gulland; James O Lloyd-Smith
Journal:  Aquat Mamm       Date:  2015-05-26       Impact factor: 1.382

4.  In vitro susceptibilities of Leptospira spp. and Borrelia burgdorferi isolates to amoxicillin, tilmicosin, and enrofloxacin.

Authors:  Doo Kim; Dorsey Kordick; Thomas Divers; Yung Fu Chang
Journal:  J Vet Sci       Date:  2006-12       Impact factor: 1.672

5.  Evaluation of pathogenic serovars of Leptospira interrogans in dairy cattle herds of Shahrekord by PCR.

Authors:  A Jafari Dehkordi; Hr Shahbazkia; N Ronagh
Journal:  Iran J Microbiol       Date:  2011-09

6.  Reduced susceptibility in leptospiral strains of bovine origin might impair antibiotic therapy.

Authors:  L Correia; A P Loureiro; W Lilenbaum
Journal:  Epidemiol Infect       Date:  2018-09-04       Impact factor: 2.451

7.  Leptospira Interrogans Serogroup Sejroe Serovar Hardjo in Aborting Cows: Two Herd Cases in Sicily (Italy).

Authors:  Francesca Grippi; Elisabetta Giudice; Simona Di Pietro; Carmela Sciacca; Francesco Santangelo; Paola Galluzzo; Santino Barreca; Annalisa Guercio
Journal:  J Vet Res       Date:  2020-03-24       Impact factor: 1.744

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.